☆ 4.7 Article

The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?

EUROPEAN JOURNAL OF CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment

Marisa C. Weiss et al.

Summary: This study found that 42% of participants used cannabis to alleviate symptoms, with pain (78%), insomnia (70%), anxiety (57%), stress (51%), and nausea/vomiting (46%) being the most common. Nearly half of cannabis users believed it could treat cancer, but only 39% had discussed it with their doctors. Many participants used cannabis during treatment despite potential risks, and most believed it to be safe without being aware of varying product quality.

CANCER (2022)

添加到收藏夹

Article Oncology

Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

A. Bessede et al.

Summary: The study reveals that acetaminophen (APAP) may suppress antitumor immunity and impact the efficacy of immunotherapy in cancer patients.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2

Swati Misri et al.

Summary: This study demonstrates that cannabidiol (CBD) inhibits the growth and metastasis of drug-resistant non-small cell lung cancer cells (NSCLC) and induces apoptosis of cisplatin-resistant cells. It acts through the TRPV2 receptor and modulates oxidative stress pathways. CBD could be a promising therapeutic strategy for cisplatin-resistant NSCLC.

CANCERS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports

Jordan Guggisberg et al.

Summary: This review examined the literature on the anticancer potential of cannabinoids, finding that most peer-reviewed case reports lack sufficient evidence to support cannabis as an anticancer agent. Strong clinical trial data are needed to confirm pre-clinical studies suggesting anticancer benefits of cannabinoids.

CANNABIS AND CANNABINOID RESEARCH (2022)

添加到收藏夹

Article Cell Biology

LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation

Mariantonia Braile et al.

Summary: Neutrophils play a central role in inflammation and tumor angiogenesis by releasing angiogenic factors. This study found that CB agonists can modulate the release of VEGF-A from LPS-activated PMNs, indicating a potential novel therapeutic strategy for patients with sepsis.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

添加到收藏夹

Article Oncology

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

Luis Paz-Ares et al.

Summary: The combination of first-line nivolumab plus ipilimumab with a limited course of chemotherapy showed a significant improvement in overall survival for patients with advanced non-small-cell lung cancer, supporting it as a new treatment option for this patient population.

LANCET ONCOLOGY (2021)

添加到收藏夹

Article Integrative & Complementary Medicine

Toward medical cannabis education in Israel

Richard Isralowitz et al.

Summary: The study conducted among Israeli medical, nursing, social work, and other health related students at Ben Gurion University of the Negev revealed a significant lack of preparedness among the students to answer patients' questions about medical cannabis, despite the majority believing in its health benefits and expressing concerns about the risks. The findings underscore the need for more knowledge and formal education on medical cannabis for students pursuing health professions in light of current regulatory and scientific advancements.

COMPLEMENTARY THERAPIES IN MEDICINE (2021)

添加到收藏夹

Article Oncology

Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis

Barliz Waissengrin et al.

Summary: This study investigated the effect of cannabis on oncologic patients with CIPN, showing that patients treated with cannabis had a lower rate of neuropathy, especially those who used cannabis prior to oxaliplatin treatment. Further large prospective trials are planned to confirm these findings.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Who is asking about medicinal cannabis in palliative care?

Stacey Panozzo et al.

INTERNAL MEDICINE JOURNAL (2020)

添加到收藏夹

Review Oncology

Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer

Farjana Afrin et al.

CANCERS (2020)

添加到收藏夹

Article Medicine, General & Internal

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

Babasola O. Okusanya et al.

SYSTEMATIC REVIEWS (2020)

添加到收藏夹

Meeting Abstract Oncology

KEYNOTE-024 5-year OS update: First-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumour proportion score (TPS) ≥50%

J. R. Brahmer et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome

Gil Bar-Sela et al.

CANCERS (2020)

添加到收藏夹

Article Substance Abuse

Trends in medical cannabis licensure, Israel, 2013-2018

Sharon R. Sznitman

DRUG AND ALCOHOL REVIEW (2020)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony S. K. Mok et al.

LANCET (2019)

添加到收藏夹

Editorial Material Oncology

Use of medical cannabis: perceptions of Israeli oncologists

Dan Mirelman et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Review Anesthesiology

Efficacy, tolerability and safety of cannabis-based medicines for cancer pain A systematic review with meta-analysis of randomised controlled trials

Winfried Haeuser et al.

SCHMERZ (2019)

添加到收藏夹

Article Oncology

Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies

Tarek Taha et al.

ONCOLOGIST (2019)

添加到收藏夹

Review Oncology

Opportunities for cannabis in supportive care in cancer

Amber S. Kleckner et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer

Lihi Bar-Lev Schleider et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

L. Gandhi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer

L. Paz-Ares et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis

Paula Berman et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Article Food Science & Technology

SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma Tumors

Yasmin Leshem et al.

TOXINS (2018)

添加到收藏夹

Review Health Care Sciences & Services

Cannabis in palliative care: current challenges and practical recommendations

Claude Cyr et al.

ANNALS OF PALLIATIVE MEDICINE (2018)

添加到收藏夹

Article Oncology

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I. S. Mosely et al.

CANCER IMMUNOLOGY RESEARCH (2017)

添加到收藏夹

Article Oncology

Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity

Yasmin Leshem et al.

CANCER IMMUNOLOGY RESEARCH (2017)

添加到收藏夹

Review Health Care Sciences & Services

A selective review of medical cannabis in cancer pain management

Alexia Blake et al.

ANNALS OF PALLIATIVE MEDICINE (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

The CB2 receptor and its role as a regulator of inflammation

Caroline Turcotte et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

添加到收藏夹

Article Plant Sciences

Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes

Oier Aizpurua-Olaizola et al.

JOURNAL OF NATURAL PRODUCTS (2016)

添加到收藏夹

Review Biochemistry & Molecular Biology

Phytocannabinoids: a unified critical inventory

Lumir Ondrej Hanus et al.

NATURAL PRODUCT REPORTS (2016)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

Martin Reck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Health Care Sciences & Services

Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience

Barliz Waissengrin et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2015)

添加到收藏夹

Article Biochemical Research Methods

Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint

Marie Fabritius et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)

添加到收藏夹

Article Neurosciences

Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease

Jill Bouchard et al.

JOURNAL OF NEUROSCIENCE (2012)

添加到收藏夹

Article Oncology

Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis

Anju Preet et al.

CANCER PREVENTION RESEARCH (2011)

添加到收藏夹

Article Pharmacology & Pharmacy

Antitumorigenic Effects of Cannabinoids beyond Apoptosis

Nadine Freimuth et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)

添加到收藏夹

Review Oncology

Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients:: systematic review and meta-analysis

F. C. Machado Rocha et al.

EUROPEAN JOURNAL OF CANCER CARE (2008)

添加到收藏夹

Article Immunology

Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response

RJ McKallip et al.

JOURNAL OF IMMUNOLOGY (2005)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cannabinoid receptors and the regulation of immune response

EV Berdyshev

CHEMISTRY AND PHYSICS OF LIPIDS (2000)

添加到收藏夹

Article Immunology

Δ-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway

LX Zhu et al.

JOURNAL OF IMMUNOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.